{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:13:00Z","timestamp":1782774780186,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602148"],"award-info":[{"award-number":["81602148"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872422, 81672871"],"award-info":[{"award-number":["81872422, 81672871"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602563, 81871977"],"award-info":[{"award-number":["81602563, 81871977"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2015J01523"],"award-info":[{"award-number":["2015J01523"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010166","name":"Xiamen Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","award":["3502Z20154025"],"award-info":[{"award-number":["3502Z20154025"]}],"id":[{"id":"10.13039\/100010166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12964-019-0387-6","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T13:04:36Z","timestamp":1562677476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Inhibition of Bcl6b promotes gastric cancer by amplifying inflammation in mice"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5323-153X","authenticated-orcid":false,"given":"Wang-Yu","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Dong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Cong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,9]]},"reference":[{"issue":"6","key":"387_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"387_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1055\/s-0031-1291491","volume":"44","author":"M Dinis-Ribeiro","year":"2012","unstructured":"Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European helicobacter study group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44:74\u201394.","journal-title":"Endoscopy"},{"key":"387_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.aau4804","volume":"361","author":"PE Hollstein","year":"2018","unstructured":"Hollstein PE, Shaw RJ. Inflamed T cells and stroma drive gut tumors. Science. 2018;361:332\u20133.","journal-title":"Science"},{"key":"387_CR4","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1007\/s10620-010-1351-x","volume":"55","author":"J Bornschein","year":"2010","unstructured":"Bornschein J, Selgrad M, Warnecke M, Kuester D, Wex T, Malfertheiner P. H. Pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci. 2010;55:3124\u201331.","journal-title":"Dig Dis Sci"},{"key":"387_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.taap.2013.05.027","volume":"273","author":"S Labib","year":"2013","unstructured":"Labib S, Guo CH, Williams A, Yauk CL, White PA, Halappanavar S. Toxicogenomic outcomes predictive of forestomach carcinogenesis following exposure to benzo(a)pyrene: relevance to human cancer risk. Toxicol Appl Pharmacol. 2013;273:269\u201380.","journal-title":"Toxicol Appl Pharmacol"},{"key":"387_CR6","doi-asserted-by":"crossref","first-page":"33444","DOI":"10.18632\/oncotarget.16800","volume":"8","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Qi X, Liu X, Zhang J, Ji J, Zhu Z, Ren J, Yu Y. Fbxw7 haploinsufficiency loses its protection against DNA damage and accelerates MNU-induced gastric carcinogenesis. Oncotarget. 2017;8:33444\u201356.","journal-title":"Oncotarget"},{"key":"387_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcimb.2018.00022","volume":"8","author":"M Tafreshi","year":"2018","unstructured":"Tafreshi M, Guan J, Gorrell RJ, Chew N, Xin Y, Deswaerte V, Rohde M, Daly RJ, Peek RM Jr, Jenkins BJ, et al. Helicobacter pylori type IV secretion system and its Adhesin subunit, CagL, mediate potent inflammatory responses in primary human endothelial cells. Front Cell Infect Microbiol. 2018;8:22.","journal-title":"Front Cell Infect Microbiol"},{"issue":"Suppl 1","key":"387_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1046\/j.1365-2036.1996.22164003.x","volume":"10","author":"JE Crabtree","year":"1996","unstructured":"Crabtree JE. Gastric mucosal inflammatory responses to helicobacter pylori. Aliment Pharmacol Ther. 1996;10(Suppl 1):29\u201337.","journal-title":"Aliment Pharmacol Ther"},{"key":"387_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmii.2016.01.002","volume":"50","author":"HF Tsai","year":"2017","unstructured":"Tsai HF, Hsu PN. Modulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis by helicobacter pylori in immune pathogenesis of gastric mucosal damage. J Microbiol Immunol Infect. 2017;50:4\u20139.","journal-title":"J Microbiol Immunol Infect"},{"key":"387_CR10","doi-asserted-by":"publisher","first-page":"e020939","DOI":"10.1136\/bmjopen-2017-020939","volume":"8","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Liu Y, Song R, Zhang L, Su Z, Li Y, Chen R, Shi N, Zhao X, Du S, et al. Validating traditional Chinese syndrome features in varied stages of chronic gastritis malignant transformation: study protocol for a cross-sectional study. BMJ Open. 2018;8:e020939.","journal-title":"BMJ Open"},{"key":"387_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1006\/bbrc.2002.6481","volume":"291","author":"C Sakashita","year":"2002","unstructured":"Sakashita C, Fukuda T, Okabe S, Kobayashi H, Hirosawa S, Tokuhisa T, Miyasaka N, Miura O, Miki T. Cloning and characterization of the human BAZF gene, a homologue of the BCL6 oncogene. Biochem Biophys Res Commun. 2002;291:567\u201373.","journal-title":"Biochem Biophys Res Commun"},{"key":"387_CR12","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1242\/dev.076539","volume":"139","author":"K Ishii","year":"2012","unstructured":"Ishii K, Kanatsu-Shinohara M, Toyokuni S, Shinohara T. FGF2 mediates mouse spermatogonial stem cell self-renewal via upregulation of Etv5 and Bcl6b through MAP2K1 activation. Development. 2012;139:1734\u201343.","journal-title":"Development"},{"key":"387_CR13","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1128\/MCB.18.7.4235","volume":"18","author":"S Okabe","year":"1998","unstructured":"Okabe S, Fukuda T, Ishibashi K, Kojima S, Okada S, Hatano M, Ebara M, Saisho H, Tokuhisa T. BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor. Mol Cell Biol. 1998;18:4235\u201344.","journal-title":"Mol Cell Biol"},{"key":"387_CR14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0006-291X(03)00396-6","volume":"303","author":"M Takenaga","year":"2003","unstructured":"Takenaga M, Hatano M, Takamori M, Yamashita Y, Okada S, Kuroda Y, Tokuhisa T. Bcl6-dependent transcriptional repression by BAZF. Biochem Biophys Res Commun. 2003;303:600\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"387_CR15","first-page":"2660","volume":"41","author":"Y Gu","year":"2018","unstructured":"Gu Y, Li A, Sun H, Li X, Zha H, Zhao J, Xie J, Zeng Z, Zhou L. BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K\/AKT signaling pathway. Int J Mol Med. 2018;41:2660\u20138.","journal-title":"Int J Mol Med"},{"key":"387_CR16","doi-asserted-by":"crossref","first-page":"11547","DOI":"10.18632\/oncotarget.3413","volume":"6","author":"X Li","year":"2015","unstructured":"Li X, Yu J, Brock MV, Tao Q, Herman JG, Liang P, Guo MZ. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU. Oncotarget. 2015;6:11547\u201360.","journal-title":"Oncotarget"},{"key":"387_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.canlet.2014.08.025","volume":"355","author":"J Wang","year":"2014","unstructured":"Wang J, Dong L, Xu L, Chu ES, Chen Y, Shen J, Li X, Wong CC, Sung JJ, Yu J. B cell CLL\/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice. Cancer Lett. 2014;355:192\u2013200.","journal-title":"Cancer Lett"},{"issue":"7","key":"387_CR18","doi-asserted-by":"publisher","first-page":"140067","DOI":"10.1098\/rsob.140067","volume":"4","author":"J. Deng","year":"2014","unstructured":"Deng J, Liang H, Dong Q, Hou Y, Xie X, Yu J, Fan D, Hao X. The survival decrease in gastric cancer is associated with the methylation of B-cell CLL\/lymphoma 6 member B promoter. Open Biol. 2014;4.","journal-title":"Open Biology"},{"key":"387_CR19","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1136\/gutjnl-2011-300411","volume":"61","author":"L Xu","year":"2012","unstructured":"Xu L, Li X, Chu ES, Zhao G, Go MY, Tao Q, Jin H, Zeng Z, Sung JJ, Yu J. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival. Gut. 2012;61:977\u201385.","journal-title":"Gut"},{"key":"387_CR20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3109\/1354750X.2013.853839","volume":"18","author":"Q Yang","year":"2013","unstructured":"Yang Q, Gao J, Xu L, Zeng Z, Sung JJ, Yu J. Promoter hypermethylation of BCL6B gene is a potential plasma DNA biomarker for gastric cancer. Biomarkers. 2013;18:721\u20135.","journal-title":"Biomarkers"},{"key":"387_CR21","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1182\/blood-2011-03-345306","volume":"119","author":"H Ohnuki","year":"2012","unstructured":"Ohnuki H, Inoue H, Takemori N, Nakayama H, Sakaue T, Fukuda S, Miwa D, Nishiwaki E, Hatano M, Tokuhisa T, et al. BAZF, a novel component of cullin3-based E3 ligase complex, mediates VEGFR and notch cross-signaling in angiogenesis. Blood. 2012;119:2688\u201398.","journal-title":"Blood"},{"key":"387_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1006\/bbrc.2001.4931","volume":"284","author":"T Hartatik","year":"2001","unstructured":"Hartatik T, Okada S, Okabe S, Arima M, Hatano M, Tokuhisa T. Binding of BAZF and Bc16 to STAT6-binding DNA sequences. Biochem Biophys Res Commun. 2001;284:26\u201332.","journal-title":"Biochem Biophys Res Commun"},{"key":"387_CR23","doi-asserted-by":"crossref","first-page":"20252","DOI":"10.18632\/oncotarget.3857","volume":"6","author":"W Wang","year":"2015","unstructured":"Wang W, Huang P, Wu P, Kong R, Xu J, Zhang L, Yang Q, Xie Q, Zhang L, Zhou X, et al. BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis. Oncotarget. 2015;6:20252\u201365.","journal-title":"Oncotarget"},{"key":"387_CR24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1136\/gutjnl-2017-314540","volume":"68","author":"F Boccellato","year":"2019","unstructured":"Boccellato F, Woelffling S, Imai-Matsushima A, Sanchez G, Goosmann C, Schmid M, Berger H, Morey P, Denecke C, Ordemann J, et al. Polarised epithelial monolayers of the gastric mucosa reveal insights into mucosal homeostasis and defence against infection. Gut. 2019;68:400\u201313.","journal-title":"Gut"},{"key":"387_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883\u201399.","journal-title":"Cell"},{"key":"387_CR26","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"387_CR27","doi-asserted-by":"crossref","unstructured":"Rugge M, Genta RM, Fassan M, Valentini E, Coati I, Guzzinati S, Savarino E, Zorzi M, Farinati F, Malfertheiner P. OLGA gastritis staging for the prediction of gastric Cancer risk: a long-term follow-up study of 7436 patients. Am J Gastroenterol. 2018.","DOI":"10.1038\/s41395-018-0353-8"},{"key":"387_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40880-017-0243-2","volume":"36","author":"K Wang","year":"2017","unstructured":"Wang K, Diao F, Ye Z, Zhang X, Zhai E, Ren H, Li T, Wu H, He Y, Cai S, et al. Prognostic value of systemic immune-inflammation index in patients with gastric cancer. Chin J Cancer. 2017;36:75.","journal-title":"Chin J Cancer"},{"key":"387_CR29","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.cgh.2017.05.023","volume":"15","author":"M Rugge","year":"2017","unstructured":"Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, Hunt RH, Kuipers EJ, Malfertheiner P, Sugano K, et al. Gastric Cancer as preventable disease. Clin Gastroenterol Hepatol. 2017;15:1833\u201343.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"387_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","volume":"9","author":"MJ Thun","year":"2012","unstructured":"Thun MJ, Jacobs EJ, Patrono C. The role of aspirin in cancer prevention. Nat Rev Clin Oncol. 2012;9:259\u201367.","journal-title":"Nat Rev Clin Oncol"},{"key":"387_CR31","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","volume":"345","author":"F Wang","year":"2014","unstructured":"Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345:196\u2013202.","journal-title":"Cancer Lett"},{"key":"387_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s10156-004-0353-Z","volume":"10","author":"M Kodama","year":"2004","unstructured":"Kodama M, Murakami K, Nishizono A, Fujioka T. Animal models for the study of helicobacter-induced gastric carcinoma. J Infect Chemother. 2004;10:316\u201325.","journal-title":"J Infect Chemother"},{"key":"387_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.15430\/JCP.2015.20.1.25","volume":"20","author":"YH Park","year":"2015","unstructured":"Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev. 2015;20:25\u201340.","journal-title":"J Cancer Prev"},{"key":"387_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3109\/00365521.2011.645501","volume":"47","author":"L Agreus","year":"2012","unstructured":"Agreus L, Kuipers EJ, Kupcinskas L, Malfertheiner P, Di Mario F, Leja M, Mahachai V, Yaron N, van Oijen M, Perez Perez G, et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol. 2012;47:136\u201347.","journal-title":"Scand J Gastroenterol"},{"key":"387_CR35","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S1470-2045(09)70358-4","volume":"10","author":"R Baan","year":"2009","unstructured":"Baan R, Grosse Y, Straif K, Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, et al. A review of human carcinogens--part F: chemical agents and related occupations. Lancet Oncol. 2009;10:1143\u20134.","journal-title":"Lancet Oncol"},{"key":"387_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/074823379100700303","volume":"7","author":"HA Hattemer-Frey","year":"1991","unstructured":"Hattemer-Frey HA, Travis CC. Benzo-a-pyrene: environmental partitioning and human exposure. Toxicol Ind Health. 1991;7:141\u201357.","journal-title":"Toxicol Ind Health"},{"key":"387_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.intimp.2015.11.036","volume":"30","author":"LN Bodduluru","year":"2016","unstructured":"Bodduluru LN, Kasala ER, Madhana RM, Barua CC, Hussain MI, Haloi P, Borah P. Naringenin ameliorates inflammation and cell proliferation in benzo(a)pyrene induced pulmonary carcinogenesis by modulating CYP1A1, NFkappaB and PCNA expression. Int Immunopharmacol. 2016;30:102\u201310.","journal-title":"Int Immunopharmacol"},{"key":"387_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.tox.2018.07.011","volume":"409","author":"C Fueldner","year":"2018","unstructured":"Fueldner C, Kohlschmidt J, Riemschneider S, Schulze F, Zoldan K, Esser C, Hauschildt S, Lehmann J. Benzo(a)pyrene attenuates the pattern-recognition-receptor induced proinflammatory phenotype of murine macrophages by inducing IL-10 expression in an aryl hydrocarbon receptor-dependent manner. Toxicology. 2018;409:80\u201390.","journal-title":"Toxicology"},{"key":"387_CR39","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1007\/s00204-018-2291-z","volume":"92","author":"DE Malik","year":"2018","unstructured":"Malik DE, David RM, Gooderham NJ. Mechanistic evidence that benzo[a]pyrene promotes an inflammatory microenvironment that drives the metastatic potential of human mammary cells. Arch Toxicol. 2018;92:3223\u201339.","journal-title":"Arch Toxicol"},{"key":"387_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.12659\/MSMBR.893945","volume":"21","author":"Q Wang","year":"2015","unstructured":"Wang Q, Xue Y. Characterization of solid tumors induced by polycyclic aromatic hydrocarbons in mice. Med Sci Monit Basic Res. 2015;21:81\u20135.","journal-title":"Med Sci Monit Basic Res"},{"key":"387_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/carcin\/19.1.117","volume":"19","author":"SJ Culp","year":"1998","unstructured":"Culp SJ, Gaylor DW, Sheldon WG, Goldstein LS, Beland FA. A comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay. Carcinogenesis. 1998;19:117\u201324.","journal-title":"Carcinogenesis"},{"key":"387_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2217\/epi.09.44","volume":"2","author":"LA Cowan","year":"2010","unstructured":"Cowan LA, Talwar S, Yang AS. Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors. Epigenomics. 2010;2:71\u201386.","journal-title":"Epigenomics"},{"key":"387_CR43","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/nbt.1724","volume":"28","author":"GS Mack","year":"2010","unstructured":"Mack GS. To selectivity and beyond. Nat Biotechnol. 2010;28:1259\u201366.","journal-title":"Nat Biotechnol"},{"key":"387_CR44","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/onc.2015.276","volume":"35","author":"W Yang","year":"2016","unstructured":"Yang W, Mok MT, Li MS, Kang W, Wang H, Chan AW, Chou JL, Chen J, Ng EK, To KF, et al. Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer development. Oncogene. 2016;35:2133\u201344.","journal-title":"Oncogene"},{"key":"387_CR45","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/ng.2983","volume":"46","author":"K Wang","year":"2014","unstructured":"Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi ST, Siu HC, Deng S, Chu KM, Law S, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014;46:573\u201382.","journal-title":"Nat Genet"},{"key":"387_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pharmthera.2018.02.006","volume":"188","author":"K Agrawal","year":"2018","unstructured":"Agrawal K, Das V, Vyas P, Hajduch M. Nucleosidic DNA demethylating epigenetic drugs - a comprehensive review from discovery to clinic. Pharmacol Ther. 2018;188:45\u201379.","journal-title":"Pharmacol Ther"},{"key":"387_CR47","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1200\/JCO.2010.30.9245","volume":"29","author":"M Lubbert","year":"2011","unstructured":"Lubbert M, Suciu S, Baila L, Ruter BH, Platzbecker U, Giagounidis A, Selleslag D, Labar B, Germing U, Salih HR, et al. Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer leukemia group and the German MDS study group. J Clin Oncol. 2011;29:1987\u201396.","journal-title":"J Clin Oncol"},{"key":"387_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1182\/blood-2006-05-021162","volume":"109","author":"H Kantarjian","year":"2007","unstructured":"Kantarjian H, Oki Y, Garcia-Manero G, Huang X, O'Brien S, Cortes J, Faderl S, Bueso-Ramos C, Ravandi F, Estrov Z, et al. Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood. 2007;109:52\u20137.","journal-title":"Blood"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-019-0387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12964-019-0387-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-019-0387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T23:11:08Z","timestamp":1594163468000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-019-0387-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,9]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["387"],"URL":"https:\/\/doi.org\/10.1186\/s12964-019-0387-6","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,9]]},"assertion":[{"value":"20 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The studies were conducted in accordance with the international ethical guidelines for biomedical research involving human subjects (CIOMS), and the research protocols were approved by the clinical research ethics Committee of Zhongshan Hospital of Xiamen University. Written informed consents were obtained from the participants before sampling.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}